Evidence map›Paper›PMID 28892490›Full record

ArticlePLoS neglected tropical diseases2017

Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.

Neetu Abad, Tasneem Malik, Archchun Ariyarajah, Patricia Ongpin, Matthew Hogben, Suzanna L R McDonald, Jaclyn Marrinan, Thomas Massaquoi, Anna Thorson, Elizabeth Ervin and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Neetu AbadSocial & Behavioral Research and Evaluation Branch, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-6999-4494
Tasneem MalikOffice of Global Activities, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Archchun AriyarajahComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Patricia OngpinStrategic information, Joint United Nations Programme on HIV/AIDS, Freetown, Sierra Leone.
Matthew HogbenSocial & Behavioral Research and Evaluation Branch, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Suzanna L R McDonaldComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Jaclyn MarrinanComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Thomas MassaquoiMilitary Hospital 34, Sierra Leone Ministry of Defence, Freetown, Sierra Leone.
Anna ThorsonDepartment of Reproductive Health and Research, Family, Women's and Children's Health, World Health Organization, Geneva, Switzerland.
Elizabeth ErvinViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kyle BernsteinEpidemiology and Statistics Branch, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Christine RossHIV Care and Treatment Branch, Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
William J LiuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Karen KroegerSocial & Behavioral Research and Evaluation Branch, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kara N DurskiPandemic and Epidemic Disease Department, Outbreaks and Health Emergencies, World Health Organization, Geneva, Switzerland.
Nathalie BroutetDepartment of Reproductive Health and Research, Family, Women's and Children's Health, World Health Organization, Geneva, Switzerland.
Barbara KnustViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Gibrilla F DeenConnaught Hospital; Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone.
Sierra Leone Ebola Virus Persistence Study Group
Centers for Disease Control and Prevention · USWorld Health Organization · CHMinistry of Defence · SLNational Institute for Viral Disease Control and Prevention · CNUniversity of Sierra Leone · SL

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundDuring the 2014-2016 West Africa Ebola Virus Disease (EVD) epidemic, the public health community had concerns that sexual transmission of the Ebola virus (EBOV) from EVD survivors was a risk, due to EBOV persistence in body fluids of EVD survivors, particularly semen. The Sierra Leone Ebola Virus Persistence Study was initiated to investigate this risk by assessing EBOV persistence in numerous body fluids of EVD survivors and providing risk reduction counseling based on test results for semen, vaginal fluid, menstrual blood, urine, rectal fluid, sweat, tears, saliva, and breast milk. This publication describes implementation of the counseling protocol and the key lessons learned. METHODOLOGY/PRINCIPAL

findingsThe Ebola Virus Persistence Risk Reduction Behavioral Counseling Protocol was developed from a framework used to prevent transmission of HIV and other sexually transmitted infections. The framework helped to identify barriers to risk reduction and facilitated the development of a personalized risk-reduction plan, particularly around condom use and abstinence. Pre-test and post-test counseling sessions included risk reduction guidance, and post-test counseling was based on the participants' individual test results. The behavioral counseling protocol enabled study staff to translate the study's body fluid test results into individualized information for study participants. CONCLUSIONS/SIGNIFICANCE: The Ebola Virus Persistence Risk Reduction Behavioral Counseling Protocol provided guidance to mitigate the risk of EBOV transmission from EVD survivors. It has since been shared with and adapted by other EVD survivor body fluid testing programs and studies in Ebola-affected countries.

Indexed as

Behavior TherapyCounselingRisk-TakingSexual BehaviorDisease Transmission, InfectiousFemaleHemorrhagic Fever, EbolaHumansMaleSierra LeoneSurvivors

Identifiers

PMID28892490
PMCPMC5593175
OpenAlexW2756075905

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.